Urology · Burbank, CA
NPI
1265543078
Since 2006
Specialty
Urology
Code 208800000X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
2701 W Alameda Ave, Ste. 506
Burbank, CA, 91505
Phone (818) 845-0611
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.2M
46,528 services
Medicare patients, 2024
1,509
Average age 76
Drug cost, 2024
$1.5M
18,974 prescriptions
Company payments, 2025
$196
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Armen A Kassabian was code J1071 (injection, testosterone cypionate, 1 mg), 25,200 times for 20 patients. In total Armen A Kassabian billed 46,528 services in 75 codes, and Medicare paid $1.2M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-07-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1071 Injection, testosterone cypionate, 1 mg | Office | 25,200 | 20 | $0.02 | $477 |
| 81001 Clinical Chemistry | Office | 3,708 | 1,237 | $3.11 | $12K |
| 99214 Office E&M - Established | Office | 3,292 | 1,126 | $99.57 | $328K |
| 76857 Ultrasound - Abdomen and Pelvis | Office | 1,990 | 957 | $41.50 | $83K |
| 99233 Hospital E&M - Subsequent | Facility | 1,628 | 278 | $96.39 | $157K |
| 76856 Ultrasound - Abdomen and Pelvis | Office | 869 | 696 | $92.80 | $81K |
| J0696 Injection, ceftriaxone sodium, per 250 mg | Office | 836 | 93 | $0.35 | $292 |
| 76775 Ultrasound - Abdomen and Pelvis | Office | 760 | 655 | $46.14 | $35K |
| 51798 Ultrasound - Nonspecific | Office | 750 | 485 | $9.32 | $6,993 |
| 96372 Injection Administration | Office | 701 | 285 | $12.32 | $8,638 |
| 86294 Immunoassay | Office | 601 | 483 | $25.06 | $15K |
| 99232 Hospital E&M - Subsequent | Facility | 575 | 121 | $64.31 | $37K |
| J3260 Injection, tobramycin sulfate, up to 80 mg | Office | 459 | 218 | $1.92 | $882 |
| 93976 Duplex Scan - Extremity Arteries | Office | 386 | 373 | $129.02 | $50K |
| 99204 Office E&M - New | Office | 368 | 368 | $115.61 | $43K |
By year: 2022 $1.1M for 55,582 services; 2023 $1.1M for 48,426 services; 2024 $1.2M for 46,528 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 81001 Clinical Chemistry | 3,708 | 1,237 | $3.11 | $12K |
| 86294 Immunoassay | 601 | 483 | $25.06 | $15K |
| 82044 Clinical Chemistry | 28 | 28 | $6.11 | $171 |
| 82570 Clinical Chemistry | 28 | 28 | $5.08 | $142 |
Medicare prescription drug claims, 2024
In 2024, the drug Armen A Kassabian prescribed most often to Medicare patients was Tamsulosin Hcl, with 4,498 prescriptions and refills. In total Armen A Kassabian wrote 18,974 Medicare prescriptions that cost $1.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Tamsulosin Hcl Generic | 4,498 | 5,106 | 673 | $25K |
| Finasteride Generic | 3,344 | 3,841 | 490 | $13K |
| Myrbetriq Mirabegron | 1,986 | 2,056 | 334 | $914K |
| Hydrocortisone Generic | 1,137 | 1,146 | 237 | $6,143 |
| Silodosin Generic | 862 | 946 | 152 | $33K |
| Oxybutynin Chloride Er Oxybutynin Chloride | 637 | 737 | 101 | $6,974 |
| Dutasteride Generic | 594 | 640 | 75 | $6,323 |
| Meloxicam Generic | 472 | 487 | 91 | $839 |
| Tadalafil Generic | 460 | 525 | 80 | $89K |
| Clotrimazole Generic | 451 | 464 | 116 | $4,320 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 438 | 438 | 272 | $681 |
| Doxazosin Mesylate Generic | 421 | 493 | 66 | $2,514 |
| Gemtesa Vibegron | 402 | 434 | 60 | $205K |
| Nitrofurantoin Mono-Macro Nitrofurantoin Monohyd/M-Cryst | 322 | 322 | 183 | $3,469 |
| Fluconazole Generic | 251 | 251 | 119 | $2,847 |
Brand drugs: - claims; generic drugs: 16,338 claims; opioid claims: 16.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Armen A Kassabian $196 ($196 in general payments such as food, travel and fees) from 2 companies. The largest payer was Amgen Inc. with $122.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.